Ranbaxy Chief Cites $300 Million Investment To Ensure Drug Quality
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories CEO and Managing Director Arund Sawhney said the company has spent more than $300 million to install state-of-the-art technology at its global facilities to ensure product safety and efficacy.